Skip to main content
Contact Us
Subscribe
E-Edition
88°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
19.16
-0.29 (-1.47%)
Streaming Delayed Price
Updated: 2:43 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger Inc
< Previous
1
2
3
4
Next >
Schrödinger to Announce Third Quarter 2022 Financial Results on November 3
October 20, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Hosts Platform Day
October 06, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Host Platform Day on October 6, 2022
September 20, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Citi’s 17th Annual BioPharma Conference
August 31, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants To Newly Appointed Chief Financial Officer
August 18, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Appoints Geoffrey Porges as Chief Financial Officer
August 18, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Second Quarter 2022 Financial Results on August 4
July 21, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Announces FDA Clearance of Investigational New Drug Application for SGR-1505, a MALT1 Inhibitor
June 28, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Convenes Global Educators For Second Annual Educator’s Day
June 22, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Jefferies Healthcare Conference
June 02, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Announces Appointment of Arun Oberoi to Board of Directors
May 19, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
May 13, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports First Quarter 2022 Financial Results
May 04, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce First Quarter 2022 Financial Results on May 4
April 20, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 19, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports New Preclinical Data Supporting Advancement of Its Wee1 Inhibitor Program at American Association of Cancer Research 2022 Annual Meeting
April 12, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021
February 24, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 17, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24
February 10, 2022
From
Schrödinger
Via
Business Wire
Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 08, 2022
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Announces Acquisition of XTAL BioStructures, Inc.
January 18, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at H.C. Wainwright BioConnect Conference
January 05, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Announces Retirement of Chief Financial Officer Joel Lebowitz
December 21, 2021
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 20, 2021
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program At American Society Of Hematology 2021 Annual Meeting
December 11, 2021
From
Schrödinger
Via
Business Wire
Schrödinger to Participate in Five Upcoming Investor Conferences
November 22, 2021
From
Schrödinger
Via
Business Wire
Schrödinger Awarded Grant to Accelerate Drug Discovery in Women’s Health
November 18, 2021
From
Schrödinger, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.